• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

稳定性增加和转录均有助于缺氧诱导尿激酶型纤溶酶原激活物受体(uPAR)的信息。

Both increased stability and transcription contribute to the induction of the urokinase plasminogen activator receptor (uPAR) message by hypoxia.

作者信息

Maity A, Solomon D

机构信息

Department of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, 19104, USA.

出版信息

Exp Cell Res. 2000 Mar 15;255(2):250-7. doi: 10.1006/excr.1999.4804.

DOI:10.1006/excr.1999.4804
PMID:10694440
Abstract

Both hypoxia and overexpression of the urokinase plasminogen activator receptor (uPAR) are associated with a poor clinical outcome in human cancers. Hypoxia has been shown to induce uPAR expression in breast cancer cells and to increase their invasion through Matrigel, a phenomenon which can be blocked using an anti-uPAR antibody. We examined expression of uPAR mRNA in MCF7 human breast carcinoma cells under hypoxia and found that an increase in the level of the message could be detected at 1% oxygen but was most marked at 0.2 or 0.05% oxygen with an induction of 9- to 20-fold over baseline. To determine whether changes in RNA stability contributed to this dramatic increase, we used actinomycin D to inhibit transcription and found that the half-life of the message was much longer under hypoxic conditions (approximately 10 h) than during reoxygenation (approximately 2 h). Transient transfections using a luciferase reporter construct containing 2 kbp of the mouse uPAR promoter showed that promoter activity increased up to 5-fold after exposure to 0.2% oxygen. Thus, hypoxic induction of the uPAR message in MCF7 cells is due to both mRNA stabilization and increased transcriptional activation.

摘要

缺氧和尿激酶型纤溶酶原激活物受体(uPAR)的过表达均与人类癌症患者的不良临床预后相关。缺氧已被证明可诱导乳腺癌细胞中uPAR的表达,并增加其通过基质胶的侵袭能力,这一现象可用抗uPAR抗体阻断。我们检测了缺氧条件下MCF7人乳腺癌细胞中uPAR mRNA的表达,发现当氧气含量为1%时即可检测到该信息水平的增加,但在氧气含量为0.2%或0.05%时最为明显,诱导倍数比基线高9至20倍。为了确定RNA稳定性的变化是否导致了这种显著增加,我们使用放线菌素D抑制转录,发现该信息在缺氧条件下的半衰期(约10小时)比复氧时(约2小时)长得多。使用含有2kbp小鼠uPAR启动子的荧光素酶报告构建体进行瞬时转染表明,暴露于0.2%氧气后,启动子活性增加了5倍。因此,MCF7细胞中uPAR信息的缺氧诱导是由于mRNA稳定性增加和转录激活增强所致。

相似文献

1
Both increased stability and transcription contribute to the induction of the urokinase plasminogen activator receptor (uPAR) message by hypoxia.稳定性增加和转录均有助于缺氧诱导尿激酶型纤溶酶原激活物受体(uPAR)的信息。
Exp Cell Res. 2000 Mar 15;255(2):250-7. doi: 10.1006/excr.1999.4804.
2
Regulation of the urokinase-type plasminogen activator receptor gene in different grades of human glioma cell lines.人不同级别胶质瘤细胞系中尿激酶型纤溶酶原激活剂受体基因的调控
Clin Cancer Res. 2001 Feb;7(2):267-76.
3
Heregulin regulation of urokinase plasminogen activator and its receptor: human breast epithelial cell invasion.Heregulin对尿激酶型纤溶酶原激活剂及其受体的调控:人乳腺上皮细胞侵袭
Cancer Res. 2001 Jan 1;61(1):400-5.
4
The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.乳腺肿瘤组织基质中的尿激酶系统与乳腺癌细胞侵袭
Int J Oncol. 2009 Jan;34(1):15-23.
5
Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87).可溶性尿激酶型纤溶酶原激活物受体(CD87)过表达可减少乳腺癌肿瘤生长及肺转移。
Cancer Gene Ther. 2000 Feb;7(2):292-9. doi: 10.1038/sj.cgt.7700144.
6
Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.乙醇诱导培养的人内皮细胞中尿激酶受体上调。
Alcohol Clin Exp Res. 2001 Feb;25(2):163-70.
7
Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor.缺氧通过上调尿激酶型纤溶酶原激活物受体促进人黑色素瘤异种移植瘤的淋巴结转移。
Cancer Res. 2002 Mar 15;62(6):1847-53.
8
DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling.DU145人前列腺癌的侵袭性受表皮生长因子受体(EGFR)信号下游的尿激酶受体(uPAR)调节。
Exp Cell Res. 2004 Sep 10;299(1):91-100. doi: 10.1016/j.yexcr.2004.05.008.
9
Effects of hypoxia and reoxygenation on the expression levels of the urokinase-type plasminogen activator, its inhibitor plasminogen activator inhibitor type-1 and the urokinase-type plasminogen activator receptor in human head and neck tumour cells.缺氧和复氧对人头颈部肿瘤细胞中尿激酶型纤溶酶原激活物、其抑制剂1型纤溶酶原激活物抑制剂及尿激酶型纤溶酶原激活物受体表达水平的影响。
Oncol Rep. 2007 May;17(5):1259-68.
10
Inhibition of urokinase receptor gene expression and cell invasion by anti-uPAR DNAzymes in osteosarcoma cells.抗尿激酶型纤溶酶原激活物受体脱氧核酶对骨肉瘤细胞尿激酶受体基因表达及细胞侵袭的抑制作用
FEBS J. 2005 Jul;272(14):3572-82. doi: 10.1111/j.1742-4658.2005.04778.x.

引用本文的文献

1
Hypoxia-dependent drivers of melanoma progression.缺氧依赖性的黑色素瘤进展驱动因素。
J Exp Clin Cancer Res. 2021 May 8;40(1):159. doi: 10.1186/s13046-021-01926-6.
2
NDRG1 deficiency attenuates fetal growth and the intrauterine response to hypoxic injury.NDRG1 缺乏可减弱胎儿生长和宫内对缺氧损伤的反应。
Endocrinology. 2014 Mar;155(3):1099-106. doi: 10.1210/en.2013-1425. Epub 2013 Jan 1.
3
The expression and function of fatty acid transport protein-2 and -4 in the murine placenta.脂肪酸转运蛋白-2 和 -4 在鼠胎盘的表达和功能。
PLoS One. 2011;6(10):e25865. doi: 10.1371/journal.pone.0025865. Epub 2011 Oct 20.
4
The tumor microenvironment and metastatic disease.肿瘤微环境与转移性疾病。
Clin Exp Metastasis. 2009;26(1):19-34. doi: 10.1007/s10585-008-9182-2. Epub 2008 Jun 10.
5
Early increases in plasminogen activator activity following partial hepatectomy in humans.人类部分肝切除术后纤溶酶原激活物活性的早期增加。
Comp Hepatol. 2004 Dec 23;3(1):11. doi: 10.1186/1476-5926-3-11.
6
Expression pattern of the urokinase-plasminogen activator system in rat DS-sarcoma: role of oxygenation status and tumour size.尿激酶-纤溶酶原激活剂系统在大鼠DS-肉瘤中的表达模式:氧合状态和肿瘤大小的作用。
Br J Cancer. 2002 Apr 22;86(8):1355-61. doi: 10.1038/sj.bjc.6600237.
7
Fending off decay: a combinatorial approach in intact cells for identifying mRNA stability elements.抵御衰变:一种在完整细胞中鉴定mRNA稳定性元件的组合方法。
RNA. 2001 Mar;7(3):435-44. doi: 10.1017/s1355838201001339.